date:Apr 25, 2014
n Danish crowns ($171 million) in the first quarter from 709 million crowns a year ago, above a forecast for 819 million crowns in a Reuters poll.
The group raised its full-year outlook and now expects operating profit to grow by 8 to 10 percent from an earlier 6 to 9 percent.
Novozymes' shares were over 4 percent higher in early trade.
The firm's sales of enzymes to the United States' bioethanol sector grew by 29 percent to 514 million crowns even though the sector's production of ethanol on